Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).Turk J Pediatr. 1991 Oct-Dec; 33(4):217-20.TJ
Abstract
Maternal antibodies against measles in 223 healthy children aged 22 to 31 weeks were studied. The ratio of children with detectable antibodies declined from 61.4 percent at 22-23 weeks of age to 20 percent at 26-27 weeks of age. Since the minimum proportion of antibody-positive children (15.6% at 26-27 weeks of age) is still higher than the optimum proportion (5%), the Schwarz vaccine which is used mostly in measles immunization seems not to be effective to obtain a high seroconversion rate in our infants. We suggest that the Edmonston-Zagreb strain of measles vaccine be used for infants under 9 months of age in Turkey.
Pub Type(s)
Journal Article
Language
eng
PubMed ID
1814038
Citation
Kanra, G, and M Ceyhan. "Elimination of Maternal Antibodies Against Measles (is the Policy of Vaccinating Children Younger Than Nine Months of Age Suitable for Turkey?)." The Turkish Journal of Pediatrics, vol. 33, no. 4, 1991, pp. 217-20.
Kanra G, Ceyhan M. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?). Turk J Pediatr. 1991;33(4):217-20.
Kanra, G., & Ceyhan, M. (1991). Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?). The Turkish Journal of Pediatrics, 33(4), 217-20.
Kanra G, Ceyhan M. Elimination of Maternal Antibodies Against Measles (is the Policy of Vaccinating Children Younger Than Nine Months of Age Suitable for Turkey?). Turk J Pediatr. 1991 Oct-Dec;33(4):217-20. PubMed PMID: 1814038.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
AU - Kanra,G,
AU - Ceyhan,M,
PY - 1991/10/1/pubmed
PY - 1991/10/1/medline
PY - 1991/10/1/entrez
SP - 217
EP - 20
JF - The Turkish journal of pediatrics
JO - Turk J Pediatr
VL - 33
IS - 4
N2 - Maternal antibodies against measles in 223 healthy children aged 22 to 31 weeks were studied. The ratio of children with detectable antibodies declined from 61.4 percent at 22-23 weeks of age to 20 percent at 26-27 weeks of age. Since the minimum proportion of antibody-positive children (15.6% at 26-27 weeks of age) is still higher than the optimum proportion (5%), the Schwarz vaccine which is used mostly in measles immunization seems not to be effective to obtain a high seroconversion rate in our infants. We suggest that the Edmonston-Zagreb strain of measles vaccine be used for infants under 9 months of age in Turkey.
SN - 0041-4301
UR - https://www.unboundmedicine.com/medline/citation/1814038/Elimination_of_maternal_antibodies_against_measles__is_the_policy_of_vaccinating_children_younger_than_nine_months_of_age_suitable_for_Turkey__
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
